StockNews.com Initiates Coverage on Retractable Technologies (NYSE:RVP)

Investment analysts at StockNews.com began coverage on shares of Retractable Technologies (NYSE:RVPGet Free Report) in a report released on Wednesday. The firm set a “hold” rating on the stock.

Retractable Technologies Stock Performance

Retractable Technologies stock opened at $1.04 on Wednesday. Retractable Technologies has a 12-month low of $0.87 and a 12-month high of $1.34. The stock has a market capitalization of $31.13 million, a price-to-earnings ratio of -4.00 and a beta of 2.08. The company has a quick ratio of 8.18, a current ratio of 11.02 and a debt-to-equity ratio of 0.01. The stock has a 50-day simple moving average of $1.13 and a 200 day simple moving average of $1.14.

Retractable Technologies (NYSE:RVPGet Free Report) last posted its quarterly earnings results on Wednesday, May 15th. The company reported $0.01 earnings per share for the quarter. Retractable Technologies had a negative net margin of 18.84% and a negative return on equity of 7.55%. The business had revenue of $7.60 million during the quarter.

Insiders Place Their Bets

In related news, CEO Thomas J. Shaw bought 48,635 shares of the business’s stock in a transaction dated Thursday, May 16th. The stock was bought at an average price of $1.03 per share, for a total transaction of $50,094.05. Following the purchase, the chief executive officer now owns 14,417,148 shares in the company, valued at approximately $14,849,662.44. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through this hyperlink. Insiders have purchased 178,338 shares of company stock valued at $185,418 in the last 90 days. 55.00% of the stock is currently owned by insiders.

Retractable Technologies Company Profile

(Get Free Report)

Retractable Technologies, Inc designs, develops, manufactures, and markets safety syringes and other safety medical products for the healthcare profession in the United States, rest of North and South America, and internationally. The company offers VanishPoint insulin syringes; tuberculin, insulin, and allergy antigen syringes; small diameter tube adapters; blood collection tube holders; allergy trays; IV safety catheters; Patient Safe syringes and Luer Caps; VanishPoint blood collection sets; EasyPoint needles; and VanishPoint autodisable syringes.

Further Reading

Receive News & Ratings for Retractable Technologies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Retractable Technologies and related companies with MarketBeat.com's FREE daily email newsletter.